Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 18, 2017; 88 (16 Supplement) April 23, 2017

Motor retraining (MoRe) for functional movement disorders: Outcomes from a one-week multidisciplinary rehabilitation program (S4.007)

Alexandra Jacob, Darryl Kaelin, Courtney Smith, Megan Jablonski, Abbey Roach, Kathrin LaFaver
First published April 17, 2017,
Alexandra Jacob
1Department of Neurology Louisville KY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryl Kaelin
2Department of Physical Medicine and Rehabilitation, University of Louisville Louisville KY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Courtney Smith
3Division of Psychology, Frazier Rehab Institute Louisville KY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan Jablonski
3Division of Psychology, Frazier Rehab Institute Louisville KY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abbey Roach
3Division of Psychology, Frazier Rehab Institute Louisville KY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathrin LaFaver
1Department of Neurology Louisville KY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Motor retraining (MoRe) for functional movement disorders: Outcomes from a one-week multidisciplinary rehabilitation program (S4.007)
Alexandra Jacob, Darryl Kaelin, Courtney Smith, Megan Jablonski, Abbey Roach, Kathrin LaFaver
Neurology Apr 2017, 88 (16 Supplement) S4.007;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To assess outcomes of patients with functional movement disorders (FMD) who underwent a one-week, inpatient motor retraining (MoRe) program.

Background: FMD are characterized by abnormal, involuntary movements that cannot be attributed to an organic cause. Patients present with a variety of symptoms including tremor, dystonia, weakness, gait or speech disturbances. These disorders are commonly seen in neurological practice and prognosis is often poor. The MoRe program is a multidisciplinary rehabilitation program with daily physical, occupational and speech therapy as well as cognitive behavioral therapy. Normal motor patterns are “relearned” by breaking down abnormal movements into individual components and gradually reconstructing normal patterns.

Design/Methods: Retrospective chart review of 32 consecutive patients admitted to the MoRe program between July 2014 to July 2016. Before and after treatment, patients were given questionnaires and were recorded on video to evaluate symptoms.

Results: 75% of patients were female and the average age was 49.1 years (SD 14.0). Average symptom duration was 7.4 years (SD 10.8). 56.0% were on disability. Patients scored 16.6 (SD 10.4) on the Becks depression inventory (BDI) and 44.1 (SD 13.9) on State-Trait Anxiety Inventory. 53.3% of patients reported PTSD symptoms and 50.0% reported a history of physical or sexual abuse. 86.5% reported improvement after the program and 69.2% maintained improvement at 6-month follow-up. Patient videos before and after the program were assessed by a Movement disorder specialist with the PMD rating scale, scores improved on average by 59.2% (p<0.05). Self-rated disability scores improved for work, social and family life related responsibilities. The program was well received by patients and 96.6% indicated they would do it again if given the opportunity.

Conclusions: Patients with FMD can be successfully treated with a one-week multidisciplinary rehabilitation program. The majority of patients maintained a meaningful improvement of symptoms at 6 months follow-up.

Disclosure: Dr. Jacob has nothing to disclose. Dr. Kaelin has received research support from Allergan and PCORI. Dr. Smith has nothing to disclose. Dr. Jablonski has nothing to disclose. Dr. Roach has nothing to disclose. Dr. LaFaver has nothing to disclose.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Dr. Robert Pitceathly and Dr. William Macken

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise